GH
CLDX icon

GAM Holding’s Celldex Therapeutics CLDX Stock Holding History

GAM Holding’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-347
Closed -$82K – 965
2015
Q4 		$82K Hold
347
– – ﹤0.01% 1082
2015
Q3 		$55K Hold
347
– – ﹤0.01% 1086
2015
Q2 		$131K Sell
347
-53
-13% -$21K ﹤0.01% 1070
2015
Q1 		$167K Hold
400
– – ﹤0.01% 963
2014
Q4 		$110K Buy
400
+180
+82% +$44.8K ﹤0.01% 1015
2014
Q3 		$43K Buy
220
+33
+18% +$7.19K ﹤0.01% 1077
2014
Q2 		$46K Buy
187
+180
+2,571% +$40.6K ﹤0.01% 1062
2014
Q1 		$2K Buy
+7
New +$2.68K ﹤0.01% 1077

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAM Holding's CLDX Position: Q1 2016 in Review

GAM Holding sold out of Celldex Therapeutics (CLDX) in Q1 2016, closing a stake of 347 shares — an estimated $82K sold.

GAM Holding first reported a position in CLDX in Q1 2014 and held it in 8 quarters. The position peaked at $167K in Q1 2015. 145 funds tracked by Wall St. Rank hold CLDX as of Q1 2016.

  • GAM Holding reported no remaining Celldex Therapeutics position as of Q1 2016 after selling out during the quarter.
  • GAM Holding sold 347 Celldex Therapeutics shares in Q1 2016, an estimated $82K.
  • GAM Holding first reported a position in Celldex Therapeutics in Q1 2014 and held it in 8 quarters.
  • GAM Holding's Celldex Therapeutics position peaked at $167K in Q1 2015.
  • 145 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q1 2016.

Based on GAM Holding's 13F filing for Q1 2016, filed 13 May 2016.